Education
About Us
Working with TipRanks
Follow Us
Jansen Valerie Malyvanh Insider Profile
4 Followers
Jansen Valerie Malyvanh, CMO at Elevation Oncology, holds 12.31K shares in Elevation Oncology (Ticker: ELEV), holds ― shares in OnKure Therapeutics (Ticker: OKUR).
Jansen Valerie Malyvanh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jansen Valerie Malyvanh holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jansen Valerie Malyvanh
Jansen Valerie Malyvanh's Trading History
Elevation Oncology
Feb 19, 2025
CMO
Uninformative Buy
8.25K
$6.28K
OnKure Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jansen Valerie Malyvanh's performance on stock
You May Also Like
Jansen Valerie Malyvanh insider profile FAQ
What is the percentage of profitable transactions made by Jansen Valerie Malyvanh?
The percentage of profitable transactions made by Jansen Valerie Malyvanh is ―.
What is the average return per transaction made by Jansen Valerie Malyvanh?
The average return per transaction made by Jansen Valerie Malyvanh is ―.
What stocks does Jansen Valerie Malyvanh hold?
Jansen Valerie Malyvanh holds: ELEV, OKUR stocks.
What was Jansen Valerie Malyvanh’s latest transaction?
Jansen Valerie Malyvanh latest transaction was an Uninformative Buy of $8.25K.
What was Jansen Valerie Malyvanh's most profitable transaction?
Jansen Valerie Malyvanh’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jansen Valerie Malyvanh's role in Elevation Oncology?
Jansen Valerie Malyvanh's role in Elevation Oncology is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.